Abstract
Introduction
Previous studies suggested that total serum bilirubin levels are negatively associated with diabetic retinopathy (DR) and nephropathy in patients with diabetes mellitus. The objective of this study was to explore the relationship between serum total bilirubin levels and prevalence of DR in patients with type 1 diabetes (T1DM) and normal renal function.
Methods
Study included 163 T1DM with normal renal function (urinary albumin excretion rate <30 mg/24 h, estimated glomerular filtration rate (eGFR) >60 ml min−11.73 m−2). Photo-documented retinopathy status was made according to the EURODIAB protocol.
Results
Patients with DR were older (49 vs 42 years, p = 0.001), had higher systolic blood pressure (130 vs 120 mmHg, p = 0.001), triglycerides (0.89 vs 0.77 mmol/L, p = 0.01), and lower serum total bilirubin (12 vs 15 U/L, p = 0.02) and eGFR (100 vs 106 ml min−11.73 m−2, p = 0.03). In multivariate logistic regression analysis, only total serum bilirubin was significantly associated with risk of DR in our subjects (OR 0.88, CI 0.81–0.96, p = 0.006).
Conclusion
These data suggest that serum total bilirubin levels are independently negatively associated with DR in T1DM with normal renal function. Prospective studies are needed to confirm whether lower serum total bilirubin has predictive value for the development of DR in T1DM with normal renal function.
Similar content being viewed by others
References
Cheung N, Mitchell P, Wong TY (2010) Diabetic retinopathy. Lancet 376:124–136
Pan HZ, Zhang H, Chang D, Li H, Sui H (2008) The change of oxidative stress products in diabetes mellitus and diabetic retinopathy. Br J Ophthalmol 92:548–551
Ram M, Singh V, Kumar D et al (2014) Antioxidant potential of bilirubin-accelerated wound healing in streptozotocin-induced diabetic rats. Naunyn Schmiedebergs Arch Pharmacol 387:955–961
Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414:813–820
Dekker D, Dorresteijn MJ, Pijnenburg M et al (2011) The bilirubin-increasing drug atazanavir improves endothelial function in patients with type 2 diabetes mellitus. Arterioscler Thromb Vasc Biol 31:458–463
Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN (1987) Bilirubin is an antioxidant of possible physiological importance. Science 235:1043–1046
Abbasi A, Deetman PE, Corpeleijn E et al (2015) Bilirubin as a potential causal factor in type 2 diabetes risk: a Mendelian randomization study. Diabetes 64:1459–1469
Djousse L, Levy D, Cupples LA et al (2001) Total serum bilirubin and risk of cardiovascular disease in the Framingham offspring study. Am J Cardiol 87:1196–1200
Cheriyath P, Gorrepati VS, Peters I et al (2010) High total bilirubin as a protective factor for diabetes mellitus: an analysis of NHANES data from 1999–2006. J Clin Med Res 2:201–206
Inoguchi T, Sasaki S, Kobayashi K, Takayanagi R, Yamada T (2007) Relationship between Gilbert syndrome and prevalence of vascular complications in patients with diabetes. JAMA 298:1396–1400
Kim ES, Lee SW, Mo EY, Moon SD, Han JH (2015) Inverse association between serum total bilirubin levels and diabetic peripheral neuropathy in patients with type 2 diabetes. Endocrine 50:405–412
Fukui M, Tanaka M, Shiraishi E et al (2008) Relationship between serum bilirubin and albuminuria in patients with type 2 diabetes. Kidney Int 74:1197–1201
Sekioka R, Tanaka M, Nishimura T, Itoh H (2015) Serum total bilirubin concentration is negatively associated with increasing severity of retinopathy in patients with type 2 diabetes mellitus. J Diabetes Complicat 29:218–221
Najam SS, Sun J, Zhang J et al (2014) Serum total bilirubin levels and prevalence of diabetic retinopathy in a Chinese population. J Diabetes 6:221–227
Nishimura T, Tanaka M, Sekioka R, Itoh H (2015) Serum bilirubin concentration is associated with eGFR and urinary albumin excretion in patients with type 1 diabetes mellitus. J Diabetes Complicat 29:1223–1227
Sekioka R, Tanaka M, Nishimura T, Itoh H (2015) Low serum total bilirubin concentration in patients with type 1 diabetes mellitus complicated by retinopathy and nephropathy. Diabetol Int 6:300–305
Grunwald JE, Alexander J, Ying GS et al (2012) Retinopathy and chronic kidney disease in the Chronic Renal Insufficiency Cohort (CRIC) study. Arch Ophthalmol 130:1136–1144
Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612
Vučić Lovrenčić M, Radišić Biljak V, Božičević S, Prašek M, Pavković P, Knotek M (2012) Estimating glomerular filtration rate (GFR) in diabetes: the performance of MDRD and CKD-EPI equations in patients with various degrees of albuminuria. Clin Biochem 45:1694–1696
Aldington SJ, Kohner EM, Meuer S, Klein R, Sjolie AK (1995) Methodology for retinal photography and assessment of diabetic retinopathy: the EURODIAB IDDM Complications Study. Diabetologia 38:437–444
Nakagami T, Toyomura K, Kinoshita T, Morisawa S (1993) A beneficial role of bile pigments as an endogenous tissue protector: anti-complement effects of biliverdin and conjugated bilirubin. Biochim Biophys Acta 1158:189–193
Kumar A, Pant P, Basu S, Rao GR, Khanna HD (2007) Oxidative stress in neonatal hyperbilirubinemia. J Trop Pediatr 53:69–71
Wu TW, Fung KP, Wu J, Yang CC, Weisel RD (1996) Antioxidant of human low density lipoprotein by unconjugated and conjugated bilirubins. Biochem Pharmacol 51:859–862
Mietus-Synder M, Friera A, Glass CK, Pitas RE (1997) Regulation of scavenger receptor expression in smooth muscle cells by protein kinase C: a role for oxidative stress. Arterioscler Thromb Vasc Biol 17:969–978
Kumari S, Panda S, Mangaraj M, Mandal MK, Mahapatra PC (2008) Plasma MDA and antioxidant vitamins in diabetic retinopathy. Indian J Clin Biochem 23:158–162
Bhutia Y, Ghosh A, Sherpa ML, Pal R, Mohanta PK (2011) Serum malondialdehyde level: surrogate stress marker in the Sikkimese diabetics. J Nat Sci Biol Med 2:107–112
Koya D, King GL (1998) Protein kinase C activation and the development of diabetic complications. Diabetes 47:859–866
Hartnett ME, Stratton RD, Browne RW, Rosner BA, Lanham RJ, Armstrong D (2000) Serum markers of oxidative stress and severity of diabetic retinopathy. Diabetes Care 23:234–240
Ishibashi F, Kawasaki A, Kojima R, Taniguchi M, Kosaka A, Uetake H (2014) Association between serum total bilirubin levels and the morphology of corneal nerve fibers in Japanese patients with uncontrolled type 2 diabetes. Diabetes Care 37:e131–e132
Cho HC (2011) The relationship among homocysteine, bilirubin, and diabetic retinopathy. Diabetes Metab J 35:595–601
Turk A, Nuhoglu I, Mentese A, Karahan SC, Erdol H, Erem C (2011) The relationship between diabetic retinopathy and serum levels of ischemia-induced albumin and malondialdehyde. Retina 31:602–608
Dave A, Kalra P, Rakshitha Gowda BH, Krishnaswamy M (2015) Association of bilirubin and malondialdehyde levels with retinopathy in type 2 diabetes mellitus. Indian J Endocrinol Metab 19:373–377
Zhu B, Wu X, Ning K, Jiang F, Zhang L (2016) The negative relationship between bilirubin level and diabetic retinopathy: a meta-analysis. PLoS ONE 11:e0161649
Funding
This study was funded by the Croatian Science Foundation (Grant No. 7459).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors disclose no conflict of interest.
Ethical approval
All procedures were in accordance with the ethical standards of the institutional committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
Rights and permissions
About this article
Cite this article
Bulum, T., Tomić, M. & Duvnjak, L. Serum bilirubin levels are negatively associated with diabetic retinopathy in patients with type 1 diabetes and normal renal function. Int Ophthalmol 38, 1095–1101 (2018). https://doi.org/10.1007/s10792-017-0565-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-017-0565-8